Correspondence 0001193125-23-213431 from Evelo Biosciences, Inc. (EVLO) (CIK 0001694665)
Evelo Biosciences, Inc. (EVLO) (CIK 0001694665)
Date: Aug. 15, 2023 · CIK: 0001694665 · Accession: 0001193125-23-213431
AI Filing Summary & Sentiment
File numbers found in text: 333-273869
Letter
Acceleration Request
Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, Massachusetts 02139
August 15, 2023
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 3010
100 F Street, N.E.
Washington, D.C. 20549
Re: EVELO BIOSCIENCES, INC.
Registration Statement on Form S-3 (Registration No. 333-273869)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333-273869) (the “Registration Statement”) of Evelo Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on August 17, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027.
If you have any questions regarding the foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration.
Very truly yours,
EVELO BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Evelo Biosciences, Inc. 620 Memorial Drive Cambridge, Massachusetts 02139 August 15, 2023 VIA EDGAR TRANSMISSION Securities and Exchange Commission Division of Corporation Finance Mail Stop 3010 100 F Street, N.E. Washington, D.C. 20549 Re: EVELO BIOSCIENCES, INC. Registration Statement on Form S-3 (Registration No. 333-273869) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333-273869) (the “Registration Statement”) of Evelo Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on August 17, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027. If you have any questions regarding the foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration. Very truly yours, EVELO BIOSCIENCES, INC. By: /s/ Balkrishan Gill Name: Balkrishan (Simba) Gill, Ph.D. Title: Chief Executive Officer cc: Peter N. Handrinos, Latham & Watkins LLP Wesley C. Holmes, Latham & Watkins LLP